Use of neuromuscular blocking drugs in the critically ill patient.
Neuromuscular blocking drugs are used routinely to facilitate the care of critically ill patients of all ages. This article addresses current uses and concerns about the appropriate administration of these drugs. Several important topics are highlighted, including basic physiology of neuromuscular transmission, blocker pharmacology, drug selection, monitoring, and future areas of research.
Coursin
D B
DB
Department of Anesthesiology, University of Wisconsin Clinical Science Center, Madison, USA.
Prielipp
R C
RC
D016292:Procedural Sedation / Q000009:adverse effects / Q000379:methods*; D003422:Critical Care; D016638:Critical Illness; D016903:Drug Monitoring; D006801:Humans; D009466:Neuromuscular Blocking Agents; D009469:Neuromuscular Junction / Q000187:drug effects / Q000502:physiology; D018579:Patient Selection
D009466:Neuromuscular Blocking Agents